The Book on AI Risk Management
A Guide for Modern Executives
In stores now!
Seizing the opportunity - while managing the risk
The first book to walk you as an executive through the maze of generative AI.As generative AI is making its way into businesses all over the world, the need to identify opportunities and manage the associated risks becomes an increasingly pressing concern. In this introductory book to AI risk management, author Johan Strömquist demystifies the topic and helps executives open up the opportunities AI is providing, while controlling the risks.The reader is walked through some of the most controversial risks associated with introducing AI into the work place. This includes:* Regulatory compliance
* AI governance
* Bias and discrimination
* Data privacy
* Intellectual property
* Operational risks
* Information security
Why is this new wave of AI different?
Generative AI is changing the business landscape. Read about what makes it different and the legacy it is built upon.
Why should I bother about AI risk?
New and easy access to advanced models offers opportunities never before seen. But to seize them, every executive needs a good understanding of how to manage the risks.
What are the different types of risks associated with AI in the workplace?
Read about several different types of AI related risks and structured approaches to managing and mitigating them.
How do I manage AI risk?
Learn how to deploy well established quality and risk management practices in a way that is adapted to the specific challenges of AI.
About the Author
Johan Strömquist is a serial entrepreneur, tech-evangelist, data privacy specialist and a Certified ITIL Service Management, as well as Change Management Expert.Since 2013 he has served as the CEO of the NDA Group, an international regulatory consulting organization supporting the life science industry in the mission to get good medicines to people who need them. His amazing team has supported a large proportion of the novel medicines that have been approved for use in Europe and the USA, and in the process, he has had the opportunity to get to know some of the finest minds in drug development and pharmaceutical regulation.With the emergence of AI as a backbone for technology driven innovation in healthcare and drug discovery, and the more recent popularization through ChatGPT and other Large Language Models, he has obsessively researched its potential impact on society, business, and people.One of the outcomes of his research happens to be this book.
Another is the founding of MPS Metalmind AB, a leader in leveraging Large Language Models to simplify and improve business processes and outcomes.
Read more about Metalmind at their website.